vip924
vincerx pharma
['vip924', 'vincerx']
vincerx pharma presents preclinical data on vip924, a first-in-class antibody-drug conjugate (adc), at the 2023 american association for cancer research (aacr) annual meeting #stocksoftheday #stockalert #stocknews #cancer #event #newclinicaltrialdata 
Find the most important news and press releases about U.S. publicly-traded companies in real-time and stay ahead of the game!